Literature DB >> 6932978

Late-appearing Philadelphia chromosome in two patients with chronic myelogenous leukemia.

R Lisker, L Casas, O Mutchinick, F Pérez-Chávez, J Labardini.   

Abstract

We describe two patients with typical myelogenous leukemia, who at the beginning of the disease lacked the Philadelphia chromosome in bone marrow cells, and 90 and 42 days later, respectively, its presence was shown in all cells analyzed from that tissue. These findings are compatible with the possibility that at least occasionally Ph1 occurs secondarily in already leukemic cells. The rapid change form Ph1- to Ph1+ CML in one of the patients (42 days), suggests the possibility that in addition to Ph1+ cells enjoying marked selective advantage, this change is induced simultaneously in multiple bone marrow cells.

Entities:  

Mesh:

Year:  1980        PMID: 6932978

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia.

Authors:  P Yotnda; H Firat; F Garcia-Pons; Z Garcia; G Gourru; J P Vernant; F A Lemonnier; V Leblond; P Langlade-Demoyen
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

Review 2.  Benign hematopoietic progenitors in chronic myeloid leukemia: current status and future prospects.

Authors:  F Cervantes; C Rozman
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

3.  Reciprocal translocation between chromosomes 8 and 9 in atypical chronic myeloid leukaemia.

Authors:  D G Oscier; G J Mufti; A Gardiner; T J Hamblin
Journal:  J Med Genet       Date:  1985-10       Impact factor: 6.318

4.  T-cell immunity to the joining region of p210BCR-ABL protein.

Authors:  W Chen; D J Peace; D K Rovira; S G You; M A Cheever
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

5.  Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.

Authors:  C R Bartram; J W Janssen; R Becher; A de Klein; G Grosveld
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

6.  C-abl and bcr are rearranged in a Ph1-negative CML patient.

Authors:  C R Bartram; E Kleihauer; A de Klein; G Grosveld; J R Teyssier; N Heisterkamp; J Groffen
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.